CORRIGENDUM to “Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma”

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394027/
https://www.ncbi.nlm.nih.gov/pubmed/32727239
http://dx.doi.org/10.1177/0300060520946862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394027/
https://www.ncbi.nlm.nih.gov/pubmed/32727239
http://dx.doi.org/10.1177/0300060520946862

Ejemplares similares